Public discourse on stem cell research in Russia: Evolution of the Agenda

Abstract

This paper studies the evolution of the media discussion surrounding stem cell research in Russia from 2001 until the issuance of the first national law in 2016 and its impact on stem cell's 'social career' in the public discourse. It analyses how the interaction of different media frames stigmatized either the biomedical technology, or the expert community. It is argued that the regulatory framework in Russia lags behind technological developments in the country and mostly reacts to signs of fraudulent actions from drug makers or practitioners. Moral issues, in contrast to the international discourse, have been not the main reason in Russia.